Robert Naso

1.8k citations

27 papers · 1.4k indexed · h-index 17

Impact in

Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
Microbiology top 2%

Papers in ⓘ

Virology 6
- HIV Research and Treatment 6
Microbiology 5
- Bacterial Infections and Vaccines 4

Co-authors: Ali Fattom (16 shared papers)Gary Horwith (4 shared papers)Ralph B. Arlinghaus (4 shared papers)Steve Fuller (3 shared papers)L.J. Arcement (2 shared papers)Larry R. Muenz (2 shared papers)Rachel Schneerson (2 shared papers)John B. Robbins (2 shared papers)
Journals: Vaccine (4 papers)Cell (2 papers)Journal of Medicinal Chemistry (2 papers)Virology (2 papers)Blood (2 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Robert Naso

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Robert Naso

Since Specialization

Citations

This map shows the geographic impact of Robert Naso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Naso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Naso more than expected).

Fields of papers citing papers by Robert Naso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Naso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Naso. The network helps show where Robert Naso may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Naso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Naso Line = papers co-authored together Robert Naso links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis New England Journal of Medicine ·Henry R. Shinefield, Steven Black, Ali Fattom, Gary Horwith, Scott Rasgon, Juan Antonio Ordóñez Pereda, Hock H. Yeoh, David Law, John B. Robbins, Rachel Schneerson, Larry R. Muenz, Steve Fuller, Joanie Johnson, Bruce Fireman, Harry Alcorn, Robert Naso	2002	351
2	A Nicotine Conjugate Vaccine Reduces Nicotine Distribution to Brain and Attenuates Its Behavioral and Cardiovascular Effects in Rats Pharmacology Biochemistry and Behavior ·Paul R. Pentel, David H. Malin, Sofiane Ennifar, Yoko Hieda, Dan E. Keyler, John R. Lake, Judit R Milstein, Lisa Basham, Ryan Coy, J.William D Moon, Robert Naso, Ali Fattom	2000	145
3	Biosynthesis of Rauscher leukemia viral proteins Cell ·Robert Naso, L.J. Arcement, Ralph B. Arlinghaus	1975	134
4	Development of StaphVAX™, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials Vaccine ·Ali Fattom, Gary Horwith, Steve Fuller, Myra Propst, Robert Naso	2003	132
5	Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers Blood ·Richard B. Stead, John S. Lambert, Dawie Wessels, Julie Iwashita, Kerstin K. Leuther, Kathryn W. Woodburn, Peter J. Schatz, Douglas M. Okamoto, Robert Naso, Anne‐Marie Duliège	2006	88
6	Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines Vaccine ·Ali Fattom, Yun Hee Cho, Chiayung Chu, Steven A. Fuller, Louis Fries, Robert Naso	1999	76
7	Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX®) in hemodialysis patients Vaccine ·Ali Fattom, Steve Fuller, Myra Propst, Scott Winston, Larry R. Muenz, David Y. He, Robert Naso, Gary Horwith	2004	75
8	Ring-Expanded (“Fat”) Nucleoside and Nucleotide Analogues Exhibit Potent in Vitro Activity against Flaviviridae NTPases/Helicases, Including Those of the West Nile Virus, Hepatitis C Virus, and Japanese Encephalitis Virus Journal of Medicinal Chemistry ·Ning Zhang, Huanming Chen, Verena Koch, Herbert Schmitz, Ching‐Len Liao, Maria Bretner, V. S. Bhadti, Ali Fattom, Robert Naso, Ramachandra S. Hosmane, Peter Borowski	2003	70
9	Potent Inhibition of NTPase/Helicase of the West Nile Virus by Ring-Expanded (“Fat”) Nucleoside Analogues Journal of Medicinal Chemistry ·Ning Zhang, Huanming Chen, Verena Koch, Herbert Schmitz, Michal Minczuk, Piotr P. Stępień, Ali Fattom, Robert Naso, Kishna Kalicharran, Peter Borowski, Ramachandra S. Hosmane	2003	53
10	Antigenic Determinants of Staphylococcus aureus Type 5 and Type 8 Capsular Polysaccharide Vaccines Infection and Immunity ·Ali Fattom, Jawad Sarwar, Lisa Basham, Sofiane Ennifar, Robert Naso	1998	44
11	Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides Vaccine ·Ali Fattom, Xiuru Li, Yun Hee Cho, A.L. Burns, Abbas Hawwari, Sara E. Shepherd, Richard T. Coughlin, Scott Winston, Robert Naso	1995	43
12	Cells transformed by certain strains of moloney sarcoma virus contain murine p60 Cell ·W G Robey, Marianne Oskarsson, George F. Vande Woude, Robert Naso, Ralph B. Arlinghaus, D. K. Haapala, Peter J. Fischinger	1977	38
13	The cell-free translation of Rauscher leukemia virus RNA into high molecular weight polypeptides Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis ·Robert Naso, L.J. Arcement, T.Gordon Wood, Thomas E. Saunders, Ralph B. Arlinghaus	1975	35
14	Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines American Heart Journal ·John B. Robbins, Rachel Schneerson, Gary Horwith, Robert Naso, Ali Fattom	2004	30
15	Staphylococcal Vaccines: A Realistic Dream Annals of Medicine ·Ali Fattom, Robert Naso	1996	19
16	in vitro inhibition of the measles virus by novel ring-expanded (‘fat’) nucleoside analogues containing the imidazo[4,5-e]diazepine ring system Bioorganic & Medicinal Chemistry Letters ·Ning Zhang, Huanming Chen, Ramesh Sood, Kishna Kalicharran, Ali Fattom, Robert Naso, Dale L. Barnard, Robert W. Sidwell, Ramachandra S. Hosmane	2002	17
17	Antiretroviral Effect of Interferon: Proposed Mechanism Journal of Interferon Research ·Robert Naso, YEONG-HUEI C. WU, Cheryl Edbauer	1982	16
18	Ribosomes from Rauscher leukemia virus-infected cells and their response to Rauscher viral RNA and polyuridylic acid Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis ·Robert Naso, Chei Suei Wang, Sophia Y. Tsai, Ralph B. Arlinghaus	1973	16
19	Capsular polysaccharide-protein conjugate vaccines Drug Discovery Today ·Ramesh Sood, Ali Fattom, Viliam Pavliak, Robert Naso	1996	14
20	C-type virus particles produced by normal mouse spleen-thymus cultures Virology ·Robert Naso, James B. Vidrine, Chei Suei Wang, Ralph B. Arlinglaus	1972	13

About Robert Naso

Robert Naso is a scholar working on Virology, Microbiology, Infectious Diseases, Immunology and Animal Science and Zoology, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (9 papers), HIV Research and Treatment (6 papers), Virus-based gene therapy research (6 papers), Pneumonia and Respiratory Infections (5 papers), Bacterial biofilms and quorum sensing (4 papers), Bacterial Infections and Vaccines (4 papers), Animal Virus Infections Studies (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Infectious Diseases (597 citations), Microbiology (174 citations), Virology (100 citations), Clinical Biochemistry (105 citations) and Immunology (230 citations). Robert Naso has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Ali Fattom, Gary Horwith, Ralph B. Arlinghaus, Steve Fuller, L.J. Arcement, Larry R. Muenz, Rachel Schneerson, John B. Robbins, David Law and Hock H. Yeoh. Their work appears in journals such as Vaccine, Cell, Journal of Medicinal Chemistry, Virology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact